{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:55:52Z","timestamp":1770882952779,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005940","name":"Dansk Kr\u00e6ftforsknings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clgc.2022.04.017","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T20:23:30Z","timestamp":1651523010000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-5163","authenticated-orcid":false,"given":"Michael","family":"Kreiberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Juul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Oturai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn Wulff","family":"Helge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Frank","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Aksglaede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Rosenvilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dehlendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gedske","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"Bandak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2022.04.017_bib0001","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2022"},{"key":"10.1016\/j.clgc.2022.04.017_bib0002","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0003","first-page":"365","article-title":"Late relapses in stage I testicular cancer patients on surveillance","volume":"70","author":"Saks\u00f8","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0004","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: Outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0005","article-title":"Cardiovascular risk factors and disease after male germ cell cancer","author":"Lauritsen","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0006","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2016.3651","article-title":"Second malignant neoplasms and cause of death in patients with germ cell cancer: A danish nationwide cohort study","volume":"2","author":"Kier","year":"2016","journal-title":"JAMA Oncol"},{"issue":"15_suppl","key":"10.1016\/j.clgc.2022.04.017_bib0007","article-title":"Psychological stress in long-term testicular cancer survivors: A Danish nationwide cohort study","volume":"36","author":"Kreiberg","year":"2019","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.clgc.2022.04.017_bib0008","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.clgc.2016.07.006","article-title":"Preorchiectomy leydig cell dysfunction in patients with testicular cancer","volume":"15","author":"Bandak","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0009","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ejca.2011.05.026","article-title":"The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer","volume":"47","author":"Bandak","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0010","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1464-410X.2012.11056.x","article-title":"Bilateral testicular germ cell tumours: A systematic review","volume":"110","author":"Zequi","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2022.04.017_bib0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2016.09.015","article-title":"Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: A population-based study","volume":"71","author":"Kier","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0012","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.eururo.2007.05.012","article-title":"The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era","volume":"52","author":"Wiechno","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0013","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1200\/JCO.2005.02.176","article-title":"The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer","volume":"23","author":"Nuver","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.2001.01297.x","article-title":"Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy","volume":"55","author":"Howell","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clgc.2022.04.017_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1470-2045(09)70287-6","article-title":"The metabolic syndrome in cancer survivors","volume":"11","author":"de Haas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2022.04.017_bib0016","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41416-020-01049-3","article-title":"Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy","volume":"Nov;123","author":"Stelwagen","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0017","unstructured":"DaTeCa (2021) Testikelkr\u00e6ft - prim\u00e6r screening, udredning, behandling, opf\u00f8lgning og senf\u00f8lger. Available at: https:\/\/www.dmcg.dk\/siteassets\/kliniske-retningslinjer\u2014skabeloner-og-vejledninger\/kliniske-retningslinjer-opdelt-pa-dmcg\/dateca\/dateca_testikel-kraft_v2.0_admgodk041121.pdf."},{"key":"10.1016\/j.clgc.2022.04.017_bib0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2015.12.042","article-title":"Reference ranges of 17-hydroxyprogesterone, DHEA, DHEAS, androstenedione, total and free testosterone determined by TurboFlow-LC\u2013MS\/MS and associations to health markers in 304 men","volume":"454","author":"Damgaard\u2013Olesen","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clgc.2022.04.017_bib0019","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/meta.2001.24916","article-title":"Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin","volume":"50","author":"Gyllenborg","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.clgc.2022.04.017_bib0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/00004872-199816100-00004","article-title":"Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure","volume":"16","author":"Rasmussen","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.clgc.2022.04.017_bib0021","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2265.2006.02722.x","article-title":"Primary testicular failure in Klinefelter's syndrome: The use of bivariate luteinizing hormone-testosterone reference charts","volume":"66","author":"Aksglaede","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clgc.2022.04.017_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3456-5","article-title":"A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)","volume":"17","author":"Bandak","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2017.07.006","article-title":"Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors","volume":"84","author":"Bandak","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0025","first-page":"1595","article-title":"Banting Lecture 1988. Role of insulin resistance in human disease. 1988","volume":"13","author":"Reaven","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/j.clgc.2022.04.017_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002960","article-title":"Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. Basu S, ed","volume":"16","author":"Walsh","year":"2019","journal-title":"PLOS Med"},{"key":"10.1016\/j.clgc.2022.04.017_bib0027","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1740774514524032","article-title":"The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men","volume":"11","author":"Snyder","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.clgc.2022.04.017_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI0,120): Comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clgc.2022.04.017_bib0029","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2022.04.017_bib0030","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-16-0505","article-title":"The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer","volume":"24","author":"Foulkes","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clgc.2022.04.017_bib0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.conctc.2018.03.008","article-title":"Different ways to estimate treatment effects in randomised controlled trials","volume":"10","author":"Twisk","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.clgc.2022.04.017_bib0032","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clgc.2022.04.017_bib0033","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2022.04.017_bib0034","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/oby.2003.98","article-title":"Sex hormones and sexual function in obese men losing weight","volume":"11","author":"Kaukua","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.clgc.2022.04.017_bib0035","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1038\/sj.ijo.0801281","article-title":"Synthesis and regulation of sex hormone-binding globulin in obesity","volume":"24","author":"Hautanen","year":"2000","journal-title":"Int J Obes"},{"key":"10.1016\/j.clgc.2022.04.017_bib0036","article-title":"Insulin-like Factor 3 Emerges from the Shadow of Testosterone as a Leydig Cell Biomarker","author":"Toppari","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:37:06Z","timestamp":1761565026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767322000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1558767322000933"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2022.04.017","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2022.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}